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Abstract
DO WOMEN TELL THEIR CONTRACEPTIVE CARE PROVIDERS ABOUT
WHEN THEY HAVE THEIR ABORTIONS?
Lisa An, Jessica Illuzzi, Clair Kaplan, and Nancy Stanwood. Section of Family
Planning, Department of Obstetrics, Gynecology, and Reproductive Sciences,
Yale University, School of Medicine, New Haven, CT.
We hypothesize that women underreport their abortions and contraceptive
failures to their contraceptive care providers. If they do underreport, then their
contraceptive care providers do not know about the contraceptive failures and
cannot adjust their contraceptive practice accordingly. Without this adjustment,
these women may receive poor contraceptive care. The political nature and
stigma surrounding abortion have isolated it from the rest of women’s health care
to the point that a gap in comprehensive contraceptive care exists. We studied
the patient side of this gap by determining women’s rate of disclosure of abortion
to their contraceptive care providers, who are separate from the abortion
providers, reasons for nondisclosure, and what factors are associated with
disclosure.
A voluntary, anonymous, self-administered questionnaire of women
seeking abortion services from Planned Parenthood of Southern New England
was conducted to determine whether women have disclosed or plan to disclose
their abortion to their contraceptive care providers. The questionnaire also
collected

information

on

contraceptive

care

provider

characteristics,

demographics, and reproductive health history. We conducted descriptive
univariate and bivariate statistics as well as logistical regression modeling around
disclosure of abortion.
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Overall, 44% of women did not disclose their abortion to their
contraceptive care provider. The most common reasons for nondisclosure of the
abortion were “I don’t want them to know I’m having an abortion” (44%), followed
by “I’m changing providers” (20%). Fourteen percent of women cited
embarrassment about the pregnancy and fear of judgment as other reasons for
nondisclosure.

Women

were

72%

less

likely

to

disclose

to

an

obstetrical/gynecological (OB/GYN) provider (adjusted OR 0.28, 95% CI 0.100.75) and 90% less likely to disclose to a non-OB/GYN provider (adjusted OR
0.10, 95% CI 0.02-0.42), compared to a Planned Parenthood contraceptive care
provider.
These results show that abortion stigma contributes to a broad shroud of
secrecy since almost half of women do not disclose their abortion to their
contraceptive care provider, who is separate from their abortion provider. Only
provider type was associated with disclosure in a statistically significant way,
while more intrinsic characteristics of the women, such as demographic or
reproductive health history factors, were not. This suggests that abortion stigma
is pervasive and can affect all types of women. Women’s health providers of any
type have a unique responsibility to continue to destigmatize abortion and
encourage use of the most effective methods of long acting reversible
contraception, such as the intrauterine device and subdermal implant. In doing
so, we may halt the unintended pregnancy epidemic in the United States.
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1
Introduction

Summary
We hypothesize that women underreport their abortions and contraceptive
failures to their contraceptive care providers. If women do underreport, then the
contraceptive care providers do not know about the patients’ contraceptive
failures and cannot adjust their contraceptive practice accordingly. Thus these
providers are partly steering blind. The political nature and stigma surrounding
abortion have isolated it from the rest of women’s health care to the point that a
gap exists between the preventative care of contraception and the treatment for
failed prevention, i.e., abortion care. In the current research, we have begun
studying the patient side of this gap by examining issues around abortion
disclosure to contraceptive care providers.

Epidemic of Unintended Pregnancy
The majority of the induced abortions in the United States occur in the
setting of an unintended pregnancy. The overall unintended pregnancy rate in
the United States has remained high over the past several years. In 2006, 6.7
million pregnancies occurred, of which 49% were unintended, compared to 48%
in 2001 (1). Low-income, cohabitating, and minority women aged 18-24 years
with less than a high school education are at especially high risk for unintended
pregnancies (2). Despite the fact that the unintended pregnancy rate remains
high, the rate of abortion among those unintended pregnancies decreased from
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47% in 2001 to 43% in 2006, while the unintended birth rate correspondingly
increased (1-2). The decline in abortions over the past few years may be
attributable to increased stigmatization for abortion and decreased access
stemming from more stringent legal restrictions or lack of enough trained
providers, or both.
To understand the potential causes of unintended pregnancy, one must
consider contraceptive use patterns. Three possible scenarios that lead to
unintended pregnancy include contraceptive nonuse, inconsistent or incorrect
contraceptive use, or contraceptive failure. In the United States, about 50% of
women with unintended pregnancy were using contraception in the cycle when
they conceived (2). Further, 60% of women who have abortions were using some
method of contraception in the month they became pregnant (3). The most
commonly used methods in the month of conception were the male condom
(28%) and oral contraceptives (14%) (3). The majority of pill users (76%) and
almost half of condom users (49%) reported using these methods inconsistently
or incorrectly, and as such, inconsistent or incorrect method use was the most
common reason these women became pregnant (3).
Among contraceptive nonusers who had abortions, 33% of them thought
that they had a low risk of becoming pregnant and 32% of them had concerns
about using contraception, including fear of side effects or problems with use in
the past (3). These findings show that women need accurate information about
both the probability of conceiving without contraception as well as the safety
profiles of the most effective methods of contraception. Since many women with
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unintended pregnancy and abortion cite difficulties with contraceptives requiring
daily use or use at every instance of sex, they would benefit more from
“forgettable” contraceptive methods, specifically the intrauterine device or
subdermal implant. These “forgettable” contraceptives, collectively called longacting reversible contracption (LARC), only require effort to have the device
placed, while having the benefit of providing up to three to ten years of highly
effective contraception thereafter. The findings also emphasize the important role
of the contraceptive care provider to give information to women, while taking
individual needs and past use into account, so that women are fully informed
when choosing a method of contraception to prevent unintended pregnancy.
Other methods of contraception that are less effective with typical use
compared to LARC include oral contraceptive pills, transdermal patch, and
vaginal ring. Oral contraceptive pills contain either combined synthetic estrogen
and progesterone or synthetic progesterone only. They inhibit ovulation and
thicken cervical mucus to prevent pregnancy. The pill requires daily use, which
can pose a challenge for some women. The transdermal patch and vaginal ring
also contain combined synthetic estrogen and progesterone and have the same
mechanism as the pill. The patch is applied to the skin and is changed weekly.
The vaginal ring is inserted in the vagina and is changed monthly. The
progesterone injection, called depot medroxyprogesterone acetate, lasts for three
months and requires repeat appointments to receive additional injections every
twelve weeks. The mechanism of the action for preventing pregnancy is inhibition
of ovulation. Other less effective methods of contraception include barrier
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methods, such as the male or female condom, diaphragm, or withdrawal (“pulling
out”). These methods require use at every instance of sex to be effective.
Condoms are important because they also provide protection against sexually
transmitted infections. The least effective methods of contraception include
fertility awareness methods, also called the rhythm method, and spermicide.
Emergency contraception, or the “morning-after pill”, consists of synthetic
progesterone. It prevents pregnancy by inhibiting ovulation, thickening cervical
mucus to prevent entry of sperm, and thinning the uterine lining to prevent
implantation of an embryo. It has no effect if the woman is already pregnant, or in
other words if an embryo has already implanted.

Abortion Provision in the United States
The statistics about abortion providers in the United States highlight the
disconnect in care between abortion and the rest of women’s health services.
Abortions are performed in a variety of settings, such as hospitals and physician
offices, but the majority (94%) occurs in the clinic setting (4). In 2008, 21% of all
abortion providers, located at high volume abortion clinics, provided the majority
of all abortions (70%) as compared to roughly the same number of providers in
general physician offices who only performed 1% of all abortions (4).
Unfortunately, the number of abortion providers has decreased significantly, by
38%, between 1982 and 2005, but has remained stable in 2008 with 1,793
providers (4).
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The decrease in abortion providers underscores the fact that the current
abortion provider pool is getting older and retiring, while the next generation of
physicians is not stepping up in adequate numbers to replace them. Many of the
current abortion providers are older physicians. They provide abortions because
they saw firsthand the serious health consequences and deaths resulting from
illegal and unsafe abortion in the United States prior to its legalization through the
landmark Supreme Court case of Roe v. Wade in 1973. The newer generations
of physicians and physicians-in-training have not seen firsthand the morbidity
and mortality related to unsafe abortion, and thus may not be aware of the
importance of continuing to learn about the medical and surgical techniques of
abortion, to then in turn provide safe and legal abortions.
The decrease in abortion providers translates into decreased access for
abortion. In the United States, 87% of counties do not have an abortion provider,
and 35% of women of reproductive age live in those counties (5). Also, 69% of
metropolitan counties do not have access to an abortion provider, and 97% of
rural counties have no abortion provider (6). Women are sometimes forced to
travel long distances for abortion services. Non-hospital providers estimate that
8% of their patients travel more than 100 miles and 19% travel 50-100 miles for
abortion services (6). The geographic barriers to abortion care are substantial.

Under-Reporting of Abortion by Women
Even though the abortion rate may have decreased over the past few
years, induced abortion overall remains a common procedure in the United
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States. About one in three women in the United States between ages 15-44
years have had at least one abortion in their lifetime (7). Despite the fact that
abortion is a common and legal procedure, women only report about 45% of
abortions performed in the United States (8-9). Another study surveying lowincome patients found 29% report the full number of abortions they have had
(10). The percentage of women under-reporting also appears to be greater in
non-white women than in white women (10-11). In terms of survey methods, selfadministered questionnaires produced higher levels of abortion reporting than
face-to-face interviews (8). Thus women under-report the occurrence and
frequency of abortion in epidemiologic studies. This under-reporting likely
transfers into the physician office when women are asked to give an obstetrical
history as part of routine gynecological care.

Abortion Stigma
Women under-report abortions because of the social stigma around
abortion in the United States. Kumar et al. in 2009 describe that abortion
transgresses three different feminine ideals of “female sexuality solely for
procreation, the inevitability of motherhood, and instinctive nurturance of the
vulnerable”. They also describe the idea of potential invisibility of abortion as
opposed to continuous stigma of diagnosable disease, such as HIV or a physical
deformity.
Some qualitative studies examining abortion stigma and issues of
disclosure more broadly have shown that there is an implicit rule of secrecy (12-
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14). The secrecy around abortion exists because women often fear that
disclosure could lead to disapproval by others, loss of social or financial support,
or they may assume that others are unwilling to listen. Other potential reasons for
women’s nondisclosure of abortions include struggle in dealing with their own
sense of morality, which may be in conflict with the abortion itself, or
embarrassment about failing to prevent an unplanned pregnancy. Concealing the
abortion often serves as a coping mechanism for the stigma to minimize any
negative consequences (12, 14). While silence may initially benefit the woman by
avoiding any conflict, it leads to a vicious cycle of repeated internalization of
negative self-perceptions and thus reinforces the stigma (15). It also leads to
feelings of isolation and deviancy despite the fact that abortion is quite common
(16). One study showed that the more stigmatized women felt, the more they felt
the need to keep their abortions a secret from friends and family (15). Almost
70% of women disclosed their emotions about the abortion “not at all” or only “a
little bit.” This led to higher rates of thought suppression and intrusive thoughts
that were associated with post-abortion psychological distress (15). In addition to
the potential for psychological distress, abortion secrecy can also lead to adverse
health consequences. A recent case report highlights two cases where women
felt the need to keep their abortion a secret, even in the setting of health
complications (17). Their need for secrecy directly led them to delay seeking care
for complications, worsening the morbidity of the complications (17). Overall the
literature shows that abortion stigma plays a detrimental role in women’s lives
and contributes to a broad shroud of secrecy.
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Abortion Disclosure to Contraceptive Care Provider
As an extension to this broad shroud of secrecy, we hypothesize that
many women do not disclose their abortions to their contraceptive care providers.
This may be during routine gynecologic history taking related to new
contraceptive care, or more directly may be around the time of experiencing an
unintended pregnancy and having an abortion. This latter scenario is our time of
interest in this study. Because abortions leave no evidence of their occurrence,
women have the ability to under-report without their contraceptive care providers
knowing otherwise. Since many women do not report their abortions in
epidemiological research, we hypothesize that women also under-report their
contraceptive failures and abortions to their contraceptive care providers. If these
providers are unaware of their patients’ abortions, they do not know their current
contraceptive care has failed and cannot modify their patients’ contraceptive
plans to better suit the patients’ needs. Ultimately, patients receive suboptimal
family planning care. Imagine the difficulty of a general primary care provider
trying to manage a diabetic patient’s medication regimen while unaware of the
glycosylated hemoglobin level or of a recent admission for diabetic ketoacidosis.
Though women often need both contraceptive care and abortion services,
a disconnect exists in the way these services are delivered. The political climate
around abortion in the United States has segregated abortion services from the
rest of women’s health care so women are often shunted to independent abortion
clinics. Some free-standing abortion clinics have high volume and subsequently
insufficient time to address comprehensive contraception care. About 60% of
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abortion centers provide only 6-15 minutes of contraceptive counseling and most
commonly provide oral contraceptives, vaginal ring, or progesterone injection
instead of more effective long-acting reversible methods (18). Only 32% of
centers surveyed provide the intrauterine device or subdermal implant
immediately postabortally, with comprehensive family planning centers being
most likely to do so (18). The other side of the disconnect in comprehensive
contraceptive services that has yet to be studied consists of clinicians who
provide contraception and not abortion who may not be aware of their patients’
contraceptive failures.
Our study addresses this disconnect from the patient perspective by
determining what proportion of women, at the time of abortion, have told or are
planning to tell their contraceptive care provider about the unintended pregnancy
and abortion. In this research, the contraceptive care provider to whom we refer
is separate from the abortion provider. We examined reasons for and factors
associated with disclosure. This specific research question has not been studied
directly, and may have significant implications for all practicing women’s health
providers.
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Statement of Purpose and Specific Aims



To determine what proportion of women, at the time of their abortion, have
told or are planning to tell their contraceptive care provider about their
pregnancy and abortion.



To determine why women do not tell their contraceptive care providers about
their abortion.



To determine factors associated with abortion disclosure to contraceptive
care providers.
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Methods

We conducted an anonymous, voluntary, self-administered, written survey
of women seeking abortion services to determine whether they have disclosed or
plan to disclose their abortion to their contraceptive care providers. The Yale
Human Investigation Committee and the Planned Parenthood Federation of
America Research Department approved the protocol. They deemed the study of
minimal risk and waived written consent because a signed written consent form
would be the only record linking the patient to the anonymous questionnaire.
An introductory statement on the survey explained the purpose of the
study and asked for voluntary participation while assuring anonymity. Decision to
participate in the survey did not affect the subject’s medical care, and subjects
had the option to decline to participate or to refrain from answering any particular
question. Each subject was instructed to read the introductory statement,
complete the survey, and then return the survey to a covered box provided in
each clinic, whether or not she had chosen to complete it. The survey was
available in English and Spanish. Contact information for study personnel was
included on the cover sheet.
Women of any age presenting for either surgical or medication abortion
care were included. Adolescents were included without parental consent since
the study was of minimal risk and because of their right to access reproductive
health care services without parental consent in general. We excluded patients
who: could not read or write in English or Spanish; did not have capacity to
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provide consent; were not pregnant or seeking abortion services; or were
prisoners or wards of the state.
The survey instrument queried participants about basic demographics,
reproductive health history, and methods of contraception used both during the
month of conception and throughout their lifetime. The survey included questions
on characteristics of the contraceptive care provider for subjects who had seen a
provider for contraceptive care in the two years prior to completing the survey.
Our main abortion disclosure outcome was elicited by the two following
questions:

“Does this [contraceptive care] provider know that you are having the
Abortion?
(1) Yes, and they referred me to an abortion provider,
(2) Yes, but they did NOT refer me to an abortion provider,
(3) No.
If NO, do you think you will tell them about the Abortion?
(1) Yes,
(2) No,
(3) No, but I will tell them I had a miscarriage,
(4) Not sure.
If you think you will NOT tell them about your Abortion, please CHECK
ALL of the reasons you don’t want to tell them:
(1) I’m embarrassed I got pregnant,
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(2) I don’t want them to know I’m having an abortion,
(3) I’m afraid they will be disappointed in me,
(4) I’m afraid they will judge me,
(5) I’m afraid other people in my life may find out about the pregnancy
from their office,
(6) They do not provide abortions,
(7) I’m afraid my parents will find out,
(8) Other reason:_______________________.”

Similar wording was used to elicit information about disclosure of the pregnancy.
See appendix for complete survey. The faculty mentor designed the first draft of
the survey. The student revised the survey through multiple iterations, gathering
and implementing feedback from the faculty mentor, Planned Parenthood’s
research department and key leadership administrators, as well as from the
Society of Family Planning Research Fund.
Study participants were recruited from the following four sites in
Connecticut that provide surgical abortion services of Planned Parenthood of
Southern New England: 1) New Haven, 2) West Hartford, 3) Stamford, and 4)
Norwich. These four clinics were chosen because of surgical abortion volumes,
staff willingness to participate in the study, and clinic resources. Staff at the
clinics offered the survey to all patients seeking medical or surgical abortions
between mid-August 2012 to November 2012, and a covered box was available
to collect the surveys after they were completed. Study subjects completed the
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surveys in the waiting room prior to administration of any sedative or abortifacient
medications. Study personnel were available by phone to answer any questions
from study participants. The target was 150 completed surveys to use in the
analysis, set as a convenience sample.
Surveys received were classified into the following categories:

1. Complete: surveys with complete disclosure questions and all or
almost all of the rest completed
2. Partially Complete: surveys that are mostly complete, except for
missing some components of the key disclosure or contraceptive care
provider questions
3. Incomplete: surveys from subjects without a contraceptive care
provider
4. Missing: surveys with many missing variables

Data entry and data coding were completed using Microsoft Excel 2008
for Mac, Version 12.3.5. Once initial data entry and data coding were complete,
every survey entry was reviewed and checked for any errors.
Next the coded data was imported into SAS for Windows, version 9.3.
Surveys from the “Complete” category were used for all statistical analyses. The
primary outcome variables examined were disclosure of abortion and disclosure
of pregnancy to contraceptive care provider. We defined disclosure as past
disclosure or intent to disclose and nondisclosure as intent not to disclose or
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unsure about disclosure. All included subjects had contraceptive care providers
who were distinct from the actual abortion providers, even if the contraceptive
care provider was through Planned Parenthood.
Descriptive univariate and bivariate statistics were calculated. The
descriptive variables examined include: age, race/ethnicity, education, income,
insurance, gravidity, parity, number of previous abortions, abortion type for
current abortion (medical or surgical), and current gestational age. The bivariate
statistics tabulated the demographics and reproductive health information by both
disclosure of pregnancy and disclosure of abortion. Chi-square analyses or
Fischer’s exact tests were calculated for the categorical variables, and Student’s
t-test for the continuous variable of age.
Descriptive univariate and bivariate statistics were calculated for
contraceptive care provider type, and length of care with that provider. We
elicited contraceptive care provider type information from participants by
separately asking what type of office and what type of provider they saw for their
contraception. We collapsed this information into a single variable for
contraceptive care provider with the following options: Planned Parenthood, other
obstetrical/gynecological (OB/GYN) clinician, and other non-OB/GYN clinician.
Note that OB/GYN provider refers to physicians who specialize in obstetrics and
gynecology as well as mid-level providers dedicated to women’s health, such as
midwives or advanced nurse practitioners in a women’s health office. The
OB/GYN provider category consists of private obstetrical/gynecological providers
who are not part of the Planned Parenthood system, while the Planned
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Parenthood category consists of contraceptive care providers who work at
Planned Parenthood, distinct from the abortion providers. The non-OB/GYN
category includes pediatricians, general medical practitioners, or any other
provider type who does not specialize in women’s health. We also calculated chisquare analyses for these variables.
Descriptive statistics on methods of contraception used in respondents’
entire lives and in the month they became pregnant were calculated, as well as
descriptive statistics on reasons for nondisclosure of pregnancy and abortion.
Lastly logistical regression modeling was used to determine what factors
are associated with disclosure of pregnancy and abortion. The model included
the following variables: age, ethnicity/race, education, income, insurance type,
gravidity, parity, previous abortions, current abortion type, current gestational
age, and contraceptive care provider characteristics. The model was used to
calculate unadjusted and adjusted odds ratios.
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Results

Study Population
A total of 427 subjects participated in our study across the four sites.
Sixty-six of those surveys were excluded because they contained too many
missing variables. Of the remaining 361 surveys, 122 were excluded because
those participants indicated that they did not have a contraceptive care provider
and an additional 37 because they had incomplete disclosure or contraceptive
care provider information (Fig. 1). The final study population consisted of 202
surveys, of which 2% were completed in Spanish and 98% in English. The
distribution of the final surveys roughly mirrors abortion volumes across the four
clinic sites: 37% from New Haven, 31% from Stamford, 17% from West Hartford,
and 15% from Norwich.

Demographics of Study Population
The mean and median ages of the participants were 26 years old and 25
years old, respectively, and the range was between 16 and 44 years. The most
common race or ethnicity was Caucasian/white at 39%, followed by African
American/black at 35%, Hispanic at 14%, and Other/Mixed at 12%. The plurality
of respondents had some college experience but without a degree at 33%,
followed by high school or equivalent at 30%, greater than some college at 28%,
and less than high school at 9%. In terms of income, almost half (46%) of the
study population was poor, earning less than $20,000 per year, a quarter (25%)
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made $20-40,000 per year, and 11% made over $40,000 per year. Mirroring the
income levels, 56% of participants had Medicaid, 27% had private insurance, and
17% were self-pay or uninsured. The demographics of the study population are
presented in Table 1.
Figure 1. Flow Chart from Initial Participants to Final Study Population

427
Initial
Participants

66
Participants with Surveys with
Many Missing Variables

361
Participants
Remaining

122
Participants with No
Contraceptive Care Provider

239
Participants
Remaining

37
Participants with Incomplete
Disclosure Information

202
Participants in Final
Study Population
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Table 1: Demographics and Reproductive Health Characteristics of Total Study
Population
Age in years

Total
n (%)
Mean 26
Median 25

Ethnicity/Race:
Hispanic
28 (14.1)
African American/black
70 (35.4)
Caucasian/white
77 (38.9)
Other: Asian, Native American, Mixed Race, or Other
23 (11.6)
Education:
Less Than High School
19 (9.4)
High School or GED
61 (30.2)
Some College
66 (32.7)
Associate’s Degree or Above
56 (27.7)
Annual Income:
Less than $20,000
90 (46.4)
$20,000-$40,000
48 (24.7)
More than $40,000
21 (10.8)
Unsure
35 (18.0)
Insurance for the Abortion:
Private
53 (26.9)
Medicaid
110 (55.8)
None, Self-Pay
34 (17.3)
Gravidity:
1
39 (19.6)
2
47 (23.6)
3
36 (18.1)
4 or more
77 (38.7)
Parity:
0
75 (37.9)
1
64 (32.3)
2
44 (22.2)
3 or more
15 (7.6)
Previous Abortions:
0
84 (42.4)
1
63 (31.8)
2
30 (15.2)
3 or more
21 (10.6)
Abortion Type Planned:
Surgical
161 (81.3)
Medical
25 (12.6)
Unsure
12 (6.1)
Gestational Age:
First Trimester
183 (92.4)
Second Trimester
9 (4.6)
Unsure
6 (3.0)
Note: Percentages may not add exactly to 100 due to rounding. A few of the variables presented above had
minimal numbers of missing data; all had less than 8 missing.
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Reproductive Health Characteristics of Study Population
The plurality of respondents, 39%, had been pregnant 4 or more times.
For 20% of women, this was their first pregnancy, and for 24% this was their
second pregnancy. However, the plurality of women (38%) had borne no
children, a third had had one child, and 22% had had two children. For 42% of
participants, this was their first abortion, 32% had one prior abortion, and 15%
had two prior abortions. The majority of women (81%) planned to undergo
surgical abortion, while 13% decided to have medication abortion. Over 90% of
respondents were in the first trimester, and only 5% were in the second trimester.
See Table 1 for more details.

Methods of Contraception
Participants most commonly used the following methods of contraception
in the month of they became pregnant: condoms (49%), withdrawal (29%), oral
contraceptives (19%), and nothing (18%). Condoms were the most common
method of contraception (87%) used in respondents’ entire lives, followed by oral
contraceptives (74%), withdrawal (50%), depot medroxyprogesterone acetate
(28%), and emergency contraception (23%). Overall, fewer than 10% of women
had ever used the most effective methods, long-acting reversible contraceptives,
such as the intrauterine device or subdermal implant. See Table 2 for more
details.
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Table 2: Most Commonly Used Methods of Contraception
In the Month of
Conception
n (%)
Withdrawal:
Withdrawal Alone
Withdrawal with Condoms
Total Withdrawal
Condoms:
Condoms Alone
Condoms with Withdrawal
Total Condoms
Oral Contraceptives:
Total Oral Contraceptives
Transdermal Patch:
Total Patch
Vaginal Ring:
Total Vaginal Ring
Depot Medroxyprogesterone Acetate (Depo):
Total Depo
Long Acting Reversible Contraception (LARC):
Total LARC
Emergency Contraception (EC):
Total EC
Nothing, I thought I wouldn’t get pregnant:
Nothing Alone
Nothing Total

Ever Used
n (%)

16 (8.0)
18 (9.0)
57 (28.6)

100 (49.5)

53 (26.6)
18 (9.0)
97 (48.7)

175 (86.6)

38 (19.1)

149 (73.8)

1 (0.5)

38 (18.8)

6 (3.0)

39 (19.3)

6 (3.0)

56 (27.7)

4 (2.0)

18 (8.9)

13 (6.5)

46 (22.8)

27 (13.4)
36 (18.1)

7 (3.5)

Note: Subjects were allowed to select multiple methods of contraception so the percentages sum to greater
than 100. Three surveys had missing data for the methods of contraception used in the month of
conception. Also, not all methods or combinations of methods are presented. Long-acting reversible
contraception is defined as the intrauterine device or subdermal implant.

Disclosure Rates
Overall, 58% of women already disclosed or plan to disclose their current
pregnancies to their contraceptive care providers, while 42% did not plan to
disclose or were unsure about disclosure. A similar percentage of respondents,
56%, already disclosed or plan to disclose their abortion to their contraceptive
care provider, and 44% did not plan to disclose or were unsure about disclosure
(Table 3). The majority of women had concordant disclosure rates for both the
pregnancy and abortion—54% already disclosed or planned to disclose both and
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40% did not plan to disclose or were unsure about disclosure of both. For this
study, we define nondisclosure to include participants who are unsure about
disclosure as well as those who do not plan to disclose. Similarly, we define
disclosure to include participants who have already disclosed or plan to disclose.
Note that disclosure to contraceptive care provider was examined, not disclosure
to the abortion provider.

Table 3: Statistics on Pregnancy and Abortion Disclosure
Disclosed

Did Not Disclose

Already Told
Provider
n (row %)

Plan to Tell
Provider
n (row %)

Total
n (total %)

Will Not
Disclose
n (row %)

Not Sure
n (row %)

Total
n (total %)

Pregnancy

90 (44)

28 (14)

118 (58)

46 (23)

38 (19)

84 (42)

Abortion

72 (36)

40 (20)

112 (56)

49 (24)

41 (20)

90 (44)

Note: Provider refers to contraceptive care provider.

Table 4 and 5 show comparisons of demographic and reproductive health
information between those who have disclosed their pregnancy and abortion and
those who have not disclosed. The chi-square, Fischer’s exact, and Student’s ttests did not show any significant differences between the participants who
disclosed and who did not disclose; the p-values were all greater than 0.05.
However, the contraceptive care provider type showed statistical significance (pvalue 0.009) when examining the differences in disclosure of pregnancy, and
approached significance (p-value 0.092) when examining the differences in
disclosure of abortion (Table 6 and 7).
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Table 4: Demographics and Reproductive Health Characteristics of Study
Population Based on Disclosure of Pregnancy
Those Who Have Not
Disclosed to Provider
n (row %)
Mean: 26.0

Those Who Have
Disclosed to Provider
n (row %)
Mean: 26.4

P-Value

Age in Years
0.6517
Ethnicity/Race:
Hispanic
12 (42.9)
16 (57.1)
African American/black
29 (41.4)
41 (58.6)
0.883
Caucasian/white
34 (44.2)
43 (55.8)
Other: Asian, Native American, 8 (34.8)
15 (65.2)
Mixed Race, or Other
Education:
Less Than High School
6 (31.6)
13 (68.4)
High School or GED
24 (39.3)
37 (60.7)
0.735
Some College
29 (43.9)
37 (56.1)
Associate’s Degree or Above
25 (44.6)
31 (55.4)
Income:
Less than $20,000
38 (42.2)
52 (57.8)
$20,000-$40,000
19 (39.6)
29 (60.4)
0.931
More than $40,000
10 (47.6)
11 (52.4)
Unsure
14 (40.0)
21 (60.0)
Insurance:
Private
18 (34.0)
35 (66.0)
0.321
Medicaid
51 (46.4)
59 (53.6)
Self-Pay
14 (41.2)
20 (58.8)
Gravidity:
1
16 (41.0)
23 (59.0)
2
26 (55.3)
21 (44.7)
0.175
3
13 (36.1)
23 (63.9)
4 or more
28 (36.4)
49 (63.6)
Parity:
0
32 (42.7)
43 (57.3)
1
26 (40.6)
38 (59.4)
0.787
2
17 (38.6)
27 (61.4)
3 or more
8 (53.3)
7 (46.7)
Previous Abortions:
0
39 (46.4)
45 (53.6)
1
28 (44.4)
35 (55.6)
0.204
2
10 (33.3)
20 (66.7)
3 or more
5 (23.8)
16 (76.2)
Abortion Type:
Surgical
64 (39.8)
97 (60.2)
0.433
Medical
13 (52.0)
12 (48.0)
Unsure
6 (50.0)
6 (50.0)
Gestational Age:
First Trimester
76 (41.5)
107 (58.5)
0.699
Second Trimester
5 (55.6)
4 (44.4)
Unsure
2 (33.3)
4 (66.7)
Note: Chi-square analyses were conducted on each variable, except for age (Student’s t-test) and
gestational age (Fischer’s exact).
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Table 5: Demographics and Reproductive Health Characteristics of Study
Population Based on Disclosure of Abortion
Those Who Have Not
Disclosed to Provider
n (row %)
Mean: 26.0

Those Who Have
Disclosed to Provider
n (%)
Mean: 26.4

P-Value

Age in Years
0.6854
Ethnicity/Race:
Hispanic
16 (57.1)
12 (42.9)
African American/black
30 (42.9)
40 (57.1)
0.544
Caucasian/white
34 (44.2)
43 (55.8)
Other: Asian, Native American, 9 (39.1)
14 (60.9)
Mixed Race, or Other
Education:
Less Than High School
6 (31.6)
13 (68.4)
High School or GED
29 (47.5)
32 (52.5)
0.674
Some College
30 (45.5)
36 (54.5)
Associate’s Degree or Above
25 (44.6)
31 (55.4)
Income:
Less than $20,000
42 (46.7)
48 (53.3)
$20,000-$40,000
20 (41.7)
28 (58.3)
0.946
More than $40,000
10 (47.6)
11 (52.4)
Unsure
16 (45.7)
19 (54.3)
Insurance:
Private
17 (32.1)
36 (67.9)
0.093
Medicaid
55 (50.0)
55 (50.0)
Self-Pay
16 (47.1)
18 (52.9)
Gravidity:
1
15 (38.5)
24 (61.5)
2
28 (59.6)
19 (40.4)
0.135
3
15 (41.7)
21 (58.3)
4 or more
31 (40.3)
46 (59.7)
Parity:
0
33 (44.0)
42 (56.0)
1
29 (45.3)
35 (54.7)
0.867
2
18 (40.9)
26 (59.1)
3 or more
8 (53.3)
7 (46.7)
Previous Abortions:
0
40 (47.6)
44 (52.4)
1
30 (47.6)
33 (52.4)
0.496
2
11 (36.7)
19 (63.3)
3 or more
7 (33.3)
14 (66.7)
Abortion Type:
Surgical
70 (43.5)
91 (56.5)
0.713
Medical
13 (52.0)
12 (48.0)
Unsure
5 (41.7)
7 (58.3)
Gestational Age:
First Trimester
81 (44.3)
102 (55.7)
0.777
Second Trimester
5 (55.6)
4 (44.4)
Unsure
3 (50.0)
3 (50.0)
Note: Chi-square analyses were conducted on each variable, except for age (Student’s t-test) and
gestational age (Fischer’s exact).
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Table 6: Contraceptive Care Provider Characteristics Based on Disclosure of
Pregnancy
Those Who Have
Not Disclosed the
Pregnancy to
Provider
n (row %)

Those Who Have
Disclosed the
Pregnancy to
Provider
n (row %)

P-Value

Total
n (total %)

Provider Type:
Planned Parenthood
10 (23.8)
32 (76.2)
42 (20.8)
OB/GYN
61 (43.9)
78 (56.1)
0.009
139 (68.8)
Other: General Medical, 13 (61.9)
8 (38.1)
21 (10.4)
Pediatric, or Not Sure
Length of Care:
Less than 6 months
16 (44.4)
20 (55.6)
36 (18.1)
6-12 months
15 (55.6)
12 (44.4)
27 (13.6)
0.178
1-2 years
19 (47.5)
21 (52.5)
40 (20.1)
More than 2 years
33 (34.4)
63 (65.6)
96 (48.2)
Note: Row percentages may not add exactly to 100 due to rounding error. Provider refers to contraceptive
care provider. OB/GYN provider is defined as physicians specializing in obstetrics and gynecology as well
as mid-level providers dedicated to women’s health, outside of Planned Parenthood.

Table 7: Contraceptive Care Provider Characteristics Based on Disclosure of
Abortion
Those Who Have
Not Disclosed the
Abortion to
Provider
n (row %)

Those Who Have
Disclosed the
Abortion to
Provider
n (row %)

P-Value

Total
n (total %)

Provider Type:
Planned Parenthood
13 (31.0)
29 (69.1)
42 (20.8)
OB/GYN
65 (46.8)
74 (53.2)
0.092
139 (68.8)
Other: General Medical, 12 (57.1)
9 (42.9)
21 (10.4)
Pediatric, or Not Sure
Length of Care:
Less than 6 months
17 (47.2)
19 (52.8)
36 (18.1)
0.090
6-12 months
17 (63.0)
10 (37.0)
27 (13.6)
1-2 years
19 (47.5)
21 (52.5)
40 (20.1)
More than 2 years
35 (36.5)
61 (63.5)
96 (48.2)
Note: Row percentages may not add exactly to 100 due to rounding error. Provider refers to contraceptive
care provider. OB/GYN provider is defined as physicians specializing in obstetrics and gynecology as well
as mid-level providers dedicated to women’s health, outside of Planned Parenthood.

Reasons for Non-Disclosure of Pregnancy and Abortion
The most common reason for non-disclosure of the pregnancy and
abortion was “I don’t want them to know I’m having an abortion” at 39% and 44%,
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respectively. Surprisingly, the respondents chose “I’m switching providers” as the
second most common reason for nondisclosure of pregnancy and abortion, at
24% and 20%, respectively. Since this was a write-in response to “other reason”,
the total number of women who have decided to switch providers is likely an
underestimation. Based on what women wrote in their “other” responses, the
main reasons for switching providers were related to relocation, insurance
changes, or general dissatisfaction for the service they received. Lower
percentages of women chose “They do not provide abortions”, “I’m embarrassed
I got pregnant”, or “I’m afraid they will judge me” (Table 8 and 9).
Table 8: Reasons for Non-Disclosure of Pregnancy
Reason
Total n (%)
I’m embarrassed I got pregnant
14 (20.0)
I don’t want them to know I’m having an abortion
27 (38.6)
I’m afraid they will be disappointed in me
9 (12.9)
I’m afraid they will judge me
11 (15.7)
I’m afraid other people in my life may find out about
6 (8.6)
the pregnancy from their office
They do not provide abortions
12 (17.1)
I’m afraid my parents will find out
6 (8.6)
I’m changing providers
17 (24.3)
Other reason
10 (14.3)
Note: The percentages sum to greater than 100 since subjects could select more than one response. The
total includes subjects who do not plan to disclose and who are not sure about disclosure. Total number of
respondents is 70.

Table 9: Reasons for Non-Disclosure of Abortion
Reason
Total n (%)
I’m embarrassed I got pregnant
10 (14.3)
I don’t want them to know I’m having an abortion
31 (44.3)
I’m afraid they will be disappointed in me
7 (10.0)
I’m afraid they will judge me
10 (14.3)
I’m afraid other people in my life may find out about
7 (10.0)
the abortion from their office
They do not provide abortions
13 (18.6)
I’m afraid my parents will find out
6 (8.6)
I’m changing providers
14 (20.0)
Other reason
13 (18.6)
Note: The percentages sum to greater than 100 since subjects could select more than one response. The
total includes subjects who do not plan to disclose and who are not sure about disclosure. Total number of
respondents is 70.
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Logistic Regression Modeling For Disclosure of Pregnancy
Logistic regression modeling was conducted for disclosure of pregnancy
to determine factors associated with disclosure. The model converged with the
inclusion of the following variables: age, ethnicity/race, education, income,
insurance type, gravidity, parity, previous abortions, abortion type planned,
current gestational age, contraceptive care provider type, and length of care with
provider. Having an OB/GYN as a contraceptive care provider was associated
with 76% lower likelihood to disclose the pregnancy to one’s provider compared
to having a Planned Parenthood contraceptive care provider (adjusted OR 0.24;
95% CI 0.08-0.70) (Table 10). In addition, the odds of disclosure of the
pregnancy are even lower to a non-OB/GYN provider compared to a Planned
Parenthood contraceptive care provider, (adjusted OR 0.05; 95% CI 0.01-0.26).
Thus, the odds of women disclosing their abortion are 95% less likely with a nonOB/GYN provider compared to a Planned Parenthood contraceptive care
provider. Note that a Planned Parenthood contraceptive care provider is distinct
from the abortion provider.
Table 10: Logistic Regression Modeling for Disclosure of Pregnancy
Factor
Age
Ethnicity/Race:
Hispanic
African American
Caucasian
Other: Asian, Native American,
Mixed Race, or Other
Education:
Less Than High School
High School or GED
Some College
Associate’s Degree or Above

Unadjusted Odds Ratio
(95% Confidence Interval)
1.01 (0.97-1.06)

Adjusted Odds Ratio
(95% Confidence Interval)
1.02 (0.94-1.11)

1.05 (0.44-2.53)
1.12 (0.58-2.15)
Reference
1.48 (0.56-3.91)

0.68 (0.20-2.37)
1.51 (0.57-3.98)
Reference
2.13 (0.59-7.73)

1.41 (0.47-4.20)
Reference
0.83 (0.41-1.68)
0.80 (0.39-1.68)

2.03 (0.43-9.59)
Reference
1.26 (0.49-3.30)
1.19 (0.37-3.78)
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Annual Income:
Less than $20,000
Reference
Reference
$20,000-$40,000
1.12 (0.55-2.28)
0.80 (0.30-2.11)
More than $40,000
0.80 (0.31-2.09)
0.46 (0.10-2.20)
Unsure
1.10 (0.50-2.43)
1.26 (0.42-3.81)
Insurance:
Private
1.68 (0.85-3.32)
4.74 (1.54-14.61)*
Medicaid
Reference
Reference
Self-Pay
1.24 (0.57-2.69)
4.65 (1.36-15.95)*
Gravidity:
1
Reference
Reference
2
0.56 (0.24-1.33)
0.41 (0.09-1.10)
3
1.23 (0.48-3.13)
1.62 (0.15-17.29)
4 or more
1.22 (0.55-2.68)
3.32 (0.17-65.55)
Parity:
0
Reference
Reference
1
1.09 (0.55-2.14)
0.69 (0.14-3.52)
2
1.18 (0.55-2.53)
0.23 (0.03-1.80)
3 or more
0.65 (0.21-1.98)
0.20 (0.02-2.53)
Previous Abortions:
0
Reference
Reference
1
1.08 (0.56-2.09)
0.73 (0.21-2.48)
2
1.73 (0.73-4.15)
0.68 (0.10-4.72)
3 or more
2.77 (0.93-8.26)
0.82 (0.13-5.37)
Abortion Type Planned:
Surgical
Reference
Reference
Medical
0.61 (0.26-1.42)
0.20 (0.06-0.65)*
Unsure
0.66 (0.20-2.14)
0.24 (0.04-1.60)
Gestational Age:
First Trimester
Reference
Reference
Second Trimester
0.57 (0.15-2.19)
1.16 (0.15-9.00)
Unsure
1.42 (0.25-7.95)
6.78 (0.39-117.12)
Provider Type:
Planned Parenthood
Reference
Reference
OB/GYN
0.40 (0.18-0.87)*
0.24 (0.08-0.70)*
*
Other: General Medical,
0.19 (0.06-0.60)
0.05 (0.01-0.26)*
Pediatric, Not Sure
Length of Care:
Less than 6 months
Reference
Reference
6-12 months
0.64 (0.23-1.75)
0.81 (0.21-3.10)
1-2 years
0.88 (0.36-2.18)
1.19 (0.33-4.33)
More than 2 years
1.53 (0.70-3.33)
2.66 (0.89-7.92)
*
statistically significant finding (p-value < 0.05)
Note: For the adjusted model, the odds ratios are calculated using 175 surveys since the statistical program
deleted 27 surveys from the model due to missing data.
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Logistic Regression Modeling For Disclosure of Abortion
Logistic regression modeling was conducted for disclosure of abortion to
determine factors associated with disclosure. As with the model for disclosure of
pregnancy, this model for abortion disclosure converged with the inclusion of the
same variables: age, ethnicity/race, education, income, insurance type, gravidity,
parity, previous abortions, abortion type planned, current gestational age,
contraceptive care provider type, and length of care with provider. Similarly,
women were 72% less likely to disclose the abortion to an OB/GYN contraceptive
care provider (adjusted OR 0.28; 95% CI 0.10-0.75), compared to a Planned
Parenthood contraceptive care provider as the reference (Table 11). In addition,
the odds of disclosure of the abortion are even lower to a non-OB/GYN provider
compared to Planned Parenthood, (adjusted OR 0.10; 95% CI 0.02-0.42). Thus,
the odds of women disclosing their abortion are 90% less likely with a nonOB/GYN provider compared to a Planned Parenthood contraceptive care
provider. Again, the Planned Parenthood contraceptive care provider is distinct
from the abortion provider.
Table 11: Logistic Regression Modeling for Disclosure of Abortion
Factor
Age
Ethnicity/Race:
Hispanic
African American
Caucasian
Other: Asian, Native American,
Mixed Race, or Other
Education:
Less Than High School
High School or GED
Some College
Associate’s Degree or Above

Unadjusted Odds Ratio
(95% Confidence Interval)
1.01 (0.96-1.06)

Adjusted Odds Ratio
(95% Confidence Interval)
0.99 (0.91-1.08)

0.59 (0.25-1.42)
1.05 (0.55-2.03)
Reference
1.23 (0.48-3.18)

0.55 (0.17-1.82)
1.48 (0.58-3.77)

1.96 (0.66-5.84)
Reference
1.09 (0.54-2.19)
1.12 (0.54-2.33)

2.07 (0.47-9.17)
Reference
1.11 (0.45-2.74)
1.32 (0.43-4.02)

1.50 (0.44-5.12)
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Annual Income:
Less than $20,000
Reference
Reference
$20,000-$40,000
1.23 (0.60-2.49)
0.87 (0.34-2.20)
More than $40,000
0.96 (0.37-2.49)
0.56 (0.13-2.42)
Unsure
1.04 (0.48-2.27)
1.27 (0.44-3.71)
Insurance:
Private
2.12 (1.07-4.21)*
4.31 (1.48-12.53)*
Medicaid
Reference
Reference
Self-Pay
1.13 (0.52-2.43)
4.25 (1.28-14.09)*
Gravidity:
1
Reference
Reference
2
0.42 (0.18-1.01)
0.31 (0.07-1.40)
3
0.88 (0.35-2.21)
0.65 (0.07-5.99)
4 or more
0.93 (0.42-2.04)
1.07 (0.06-18.07)
Parity:
0
Reference
Reference
1
0.95 (0.49-1.86)
1.35 (0.29-6.22)
2
1.14 (0.53-2.41)
0.60 (0.09-3.96)
3 or more
0.69 (0.23-2.09)
0.55 (0.05-6.20)
Previous Abortions:
0
Reference
Reference
1
1.00 (0.52-1.92)
0.90 (0.28-2.90)
2
1.57 (0.67-3.70)
0.97 (0.16-5.10)
3 or more
1.82 (0.67-4.96)
0.72 (0.12-4.40)
Abortion Type Planned:
Surgical
Reference
Reference
Medical
0.71 (0.31-1.65)
0.25 (0.08-0.81)*
Unsure
1.08 (0.33-3.53)
0.34 (0.06-1.90)
Gestational Age:
First Trimester
Reference
Reference
Second Trimester
0.64 (0.17-2.44)
1.15 (0.16-8.48)
Unsure
0.79 (0.16-4.04)
1.85 (0.15-23.18)
Provider Type:
Planned Parenthood
Reference
Reference
OB/GYN
0.51 (0.25-1.06)
0.28 (0.10-0.75)*
*
Other: General Medical,
0.34 (0.11-0.99)
0.10 (0.02-0.42)*
Pediatric, Not Sure
Length of Care:
Less than 6 months
Reference
Reference
6-12 months
0.53 (0.19-1.46)
0.72 (0.19-2.69)
1-2 years
0.99 (0.40-2.44)
1.64 (0.49-5.56)
More than 2 years
1.56 (0.72-3.39)
3.04 (1.07-8.65)*
*
statistically significant (p-value <0.05)
Note: For the adjusted model, the odds ratios are calculated using 176 surveys since the statistical program
deleted 26 surveys from the model due to missing data.

The association of contraceptive care provider type to disclosure of abortion was
similar to the results from the disclosure of pregnancy model.
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In creating the adjusted model, the statistical program deleted 26 surveys
due to missing variables. As such, some variables showed a new finding of
statistical significance, such as insurance type, abortion type planned, or length
of care with provider. However, the p-values for these variables from the chisquare calculations with the bivariate statistics and in the unadjusted model were
greater than 0.05. The exclusion of 26 surveys in the adjusted model likely
skewed this result since this finding was not stable across all calculations. The
rest of the odds ratios showed that the remainder of demographics and
reproductive health variables had 95% confidence intervals that crossed the null
value in both the unadjusted and adjusted models.
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Discussion

Interpretation of Disclosure Data
Almost half of women in our study did not disclose their unintended
pregnancy or their abortion to their contraceptive care providers. Disclosure was
associated with provider type, with women being significantly more likely to
disclose to their pre-established Planned Parenthood clinician who is distinct
from the abortion provider than to a separate private OB/GYN clinician or nonOB/GYN

clinician.

No

other factors–including

demographics,

education,

insurance status, and income–were consistently associated with disclosure in our
analysis.
The reasons for nondisclosure of abortion highlight that fear of stigma is
common. Our findings echo other research showing that abortion stigma leads to
secrecy of the abortion (12-16, 17). Surprisingly, almost a quarter of women
surveyed who chose not to disclose their pregnancy or abortion felt the need to
change providers. We are probably underestimating the total number of women
who feel this way because this response was gleaned from written responses in
the “other” category. This finding may indicate that many women are unhappy
with care they received and may blame the provider in part for the unplanned
pregnancy. Alternatively, they may fear judgment by these providers, and this
may prompt their switch in providers. Other common reasons for nondisclosure
were “I’m embarrassed I got pregnant” and “I’m afraid they [my provider] will
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judge me”, further underscoring that women fear potential judgment and negative
attitudes from their providers if they disclose.
Women feel the most comfortable disclosing their pregnancy and abortion
to a Planned Parenthood contraceptive care provider compared to a general
OB/GYN provider or to other types of providers, such as a general practitioner or
pediatrician. Note that we define OB/GYN provider as physicians or mid-level
providers devoted to women’s health, such as midwives or advanced nurse
practitioners, who practice outside of the Planned Parenthood setting. This
finding suggests that women perceive Planned Parenthood to be less or nonjudgmental in regards to unplanned pregnancy and abortion when compared to
other reproductive health care clinicians or non-OB/GYN clinicians. This is in line
with the findings of Major and Gramzow that showed that women are less likely
to disclose their abortion if they feel like they may be judged negatively (15).
Planned Parenthood is known for supporting the full range of women’s
reproductive health decisions, and our data mirrors women’s perception of this
fact. Another possible interpretation is that the type of women who go to Planned
Parenthood for their abortion and contraceptive care may already feel less
stigmatized from abortion at baseline, and thus would be more likely to disclose.
In addition, our finding from the logistical regression modeling that women
with private insurance or women who self-pay were more likely to disclose than
women with Medicaid is likely a spurious result. From the chi-square analyses of
the bivariate statistics, this finding was not significant as the p-values were
greater than 0.05. Only with the adjusted model did the odds ratios appear

34
significant with a confidence interval that did not cross one for both disclosure of
pregnancy and abortion. Since a few of the surveys in our study population
contained some missing variables, the statistical program removed those from
the adjusted model. This likely skewed the results as our total sample size is
small.
It is interesting that all of the intrinsic characteristics we examined, such as
race/ethnicity, age, income, education level, gravidity, or parity, were not
associated with disclosure in any statistically significant way. Only the provider
type showed any robust associations with disclosure of pregnancy and abortion.
This suggests that abortion stigma is pervasive across all types of women.
Women of any socioeconomic status, race/ethnicity, or age may feel the negative
effects of abortion stigma that can lead to nondisclosure.

Implications of Nondisclosure of Abortion
Nondisclosure of abortion can harm women’s health if the desire for
nondisclosure supersedes sound decision-making around potential health
complications. Although the complication rate for abortion in the United States is
extremely low, nondisclosure of abortion has the potential to exacerbate
complications when they do occur. A recent case report published in Obstetrics
and Gynecology describes unsafe consequences if women continue to keep their
abortions a secret (17). One of the cases described a woman who had ruptured
membranes after laminaria were placed that led to an infection. Even in the
setting of threatened sepsis, she chose to keep silent in fear of facing any stigma
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from others. She eventually was rushed to the hospital by ambulance after her
condition deteriorated. This whole situation may have been averted if the woman
did not feel so stigmatized for the abortion to the point that she would rather risk
her own health than disclose the abortion. This example depicts the harms that
may result from nondisclosure of abortion and how abortion stigma contributes to
a harmful shroud of secrecy.
The case report example underscores the harmful effects of nondisclosure
of one’s pregnancy and abortion to family members and friends. Imagine that
even after the abortion, as the woman continues contraceptive care with her
women’s health provider, she omits this valuable past medical history. The
provider, unknowingly, would continue prescribing a suboptimal contraceptive
regimen, such as oral contraceptives, instead of more effective methods. Typical
use of oral contraceptives has a 9% failure rate, and its inconsistent use probably
led to the unplanned pregnancy and the abortion in the first place, as the majority
of cases do (3). A general physician or endocrinologist would agree that a similar
situation with a diabetic patient who chooses to keep an admission to the
intensive care unit for diabetic ketoacidosis a secret would be considered an
obstacle to a basic standard of patient care. In addition, if the glycosylated
hemoglobin remained elevated with metformin alone, why would the provider
continue this regimen instead of starting insulin, which would provide more
effective glycemic control? The bottom line is that secrecy about abortion can
harm women’s health and contributes to the epidemic of unintended
pregnancy.
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A possible solution to the abortion stigma and nondisclosure dilemma lies
in destigmatizing abortion, creating an environment where women feel safe to
disclose, and supporting patients in a neutral, non-judgmental way. A qualitative
study on abortion stigma described a theme of dissatisfaction with health
professional attitudes and demeanors that the women perceived as “judgmental”
(14). Another study piloted an intervention of introducing women who had had a
recent abortion to a “culture of support” by providing validating messages and
information about groups and services that support women in their reproductive
decisions (19). The intervention consisted of a documentary screening about
women’s experiences with abortion, a brochure containing validating messages
about their decision for an abortion and contact information for accurate sources
of reproductive health information, and the opportunity to discuss their
experiences in a group setting (19). The messaging conveyed to the women
framed abortion as the “end result of caring and moral women making hard
choices” (19). All participants agreed that the intervention was useful, especially
the emphasis on how “other women go through this, too” and the positive framing
of abortion decisions (19). Most women felt that they could be more resilient to
the negative attitudes and judgments from others after the intervention (19). We
as health providers need to carry over these lessons learned to create
environments where patients feel comfortable disclosing without judgment.

A Focus on Comprehensive Contraceptive Care
Once providers establish a safe environment for women to disclose their
abortions, we can then focus on more important issues, such as why the
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unplanned pregnancy occurred in the first place and what can be done to prevent
another in the future. Ultimately the goal should be about how to find the
appropriate method of contraception to shift the focus to prevention of
unintended pregnancy. Diabetics need to maintain a medication regimen to keep
their glycosylated hemoglobin at goal to prevent a complication like diabetic
ketoacidosis, and similarly, women need to find the best contraceptive regimen to
prevent an unintended pregnancy and abortion.
Sixty percent of women with unintended pregnancy who undergo abortion
used contraception in the month they became pregnant, but the majority of them
used it inconsistently or incorrectly (3). This presents a golden opportunity for
contraceptive care providers to intervene. If we want to curb the unintended
pregnancy epidemic, the focus should shift to encouraging use of the most
effective methods of reversible birth control that are “forgettable”, namely the
intrauterine device (IUD) or subdermal implant, collectively called long-acting
reversible contraception (LARC). LARC eliminates the need to remember to do
anything, such as take a daily pill, change a weekly transdermal patch, or change
a monthly vaginal ring. In a prospective study, the pill, patch, and ring had
contraceptive failure rates that were twenty times higher than with LARC, and
women younger than 21 years had double the failure rate with the pill, patch, and
ring compared to women over 21 years (20). Other retrospective studies show
similar

findings

of

LARC

effectiveness

compared

to

other

reversible

contraception, with the following failure rates: 9% for oral contraceptives, 0.001%
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for subdermal implant, 0.14% for levonorgestrel IUD, 0.7% for copper IUD (2122).
Despite the fact that LARC methods are the most effective, women in the
United States more commonly use less effective methods of birth control, such
as oral contraceptives. If we as providers can reframe the way we counsel our
patients by presenting LARC methods as the most effective at preventing
pregnancy, we will start to see improvement in unintended pregnancy, abortion,
and repeat abortion rates. The Contraceptive CHOICE project in St. Louis
showed that contraceptive counseling that included information on all reversible
methods with emphasis on the superior effectiveness of LARC along with the
provision of contraception at no cost had a positive impact on reducing the
abortion rate among study participants compared to the rest of the region and
nation (23).
LARC methods can save expenditures in our health care system.
Annually, deliveries from unintended pregnancy alone cost the United States
about $4.6 billion dollars (24). If only 10% of women on non-LARC methods of
contraception or no contraception switched to LARC, it would save the United
States $436 million dollars per year (24). This is an underestimate of the real cost
savings because only the costs related to deliveries from unintended pregnancy
are considered in this study, and not the cost savings from averting the need for
prenatal care or other social and health services related to dealing with
unintended pregnancy (24).
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While the advantages of LARC methods are numerous, its provision in the
United States is low, especially in the post-abortion setting. About 60% of
abortion centers provide only 6-15 minutes of contraceptive counseling and most
commonly provide oral contraceptives, vaginal ring, or progesterone injection
instead of more effective LARC methods (18). Only 32% of centers surveyed
provide the intrauterine device or subdermal implant immediately postabortally,
with comprehensive family planning centers being most likely to do so (18). Even
though the disconnect in care exists between contraception and abortion care
that may exacerbate the underutilization of LARC methods, the messaging
around contraception needs to change at all levels—from a contraceptive care
provider who does not provide abortions to abortion providers who do not spend
enough time on contraceptive counseling.

Limitations
Our study is limited by its relatively small sample size, which we set as a
convenience sample. However, we were still able to gather some interesting and
robust results. There may also be an element of selection bias, since the women
who chose to participate may differ from those who did not participate. Another
limitation relates to the number of surveys that contained missing data. By
excluding those surveys from our study, the results may not be representative.
The results may not be generalizable to other geographic and health care
settings. Study subjects were recruited from a setting that predominantly serves
women of low socioeconomic status and minority demographics in the Northeast,
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which has less restrictive abortion laws compared to other regions, such as the
South or Midwest. Although abortion stigma is real and tangible in this region, it
may be of a lesser degree compared to other parts of the country and could
affect disclosure rates.

Future Directions
We envisioned this study as a pilot, with the expectation that we would
improve upon the survey and expand it to a wider variety of women across the
United States. We hope to collaborate with other centers of abortion care in
different regions, including areas where abortion may be more stigmatized and
marginalized.

Conclusions
Almost half of women did not disclose their abortion to their contraceptive
care provider. The most common reasons for nondisclosure of the abortion were
“I don’t want them to know I’m having an abortion” (44%), followed by “I’m
changing providers” (20%). The common reasons why these women do not
disclose are due to underlying abortion stigma and their fear of judgment and
negative treatment from providers. Women were 72% less likely to disclose their
abortion to an obstetrical/gynecological (OB/GYN) provider outside of the
Planned Parenthood system (adjusted OR 0.28, 95% CI 0.10-0.75) and 90% less
likely to disclose to a non-OB/GYN provider (adjusted OR 0.10, 95% CI 0.020.42), compared to a Planned Parenthood contraceptive care provider. The
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association of contraceptive care provider characteristics with disclosure, rather
than more internal characteristics of the woman herself, demonstrates the
pervasive nature of abortion stigma. The political nature and stigma surrounding
abortion have isolated it from the rest of women’s health care to the point that a
gap exists between the preventative care of contraception and abortion care,
which is the treatment for failed prevention. Nondisclosure of abortion can lead to
potential health complications or the continuation of suboptimal contraceptive
regimens. Contraceptive care providers of any type are in a unique position not
only to continue destigmatizing abortion, but also to encourage the use of the
most effective reversible methods of contraception, including the intrauterine
device and subdermal implant. In doing so we may curb the unintended
pregnancy epidemic in the United States.
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Appendix: Survey Instrument
Pregnancy Conversations
We are interested to know what women have talked about with their
contraceptive providers before they come for an abortion.
Thank you for doing this short, ANONYMOUS survey. We are grateful for
your honest and careful answers. Filling out this survey is completely
voluntary and confidential. Your care today will not be affected by your
decision to do this survey. Your name or other identifying information will
NOT be recorded. Feel free to skip any questions you do not wish to
answer. If you have any concerns from doing the survey, please ask to
speak with the research coordinator or call the phone number below.
Please do NOT fill out this survey if:
- You are not presenting for abortion services
- You are currently a prisoner
- You are currently a ward of the state, that is you are younger than
eighteen and currently cared for by the Department of Children and
Families
Please return this packet to the PURPLE container marked “Pregnancy
Conversations SURVEYS” at the front desk.
If you want to keep our contact information, please keep this first page but
return the rest of the packet.
Thank you!
Nancy L. Stanwood, MD, MPH, (203) 737-4665
Clair Kaplan, MSN/APRN, MHS, (203) 752-2864
Lisa An, Medical Student

Version 2 as of July 11, 2012

Clinic Location:  New Haven  Norwich  West Hartford  Stamford

Pregnancy Conversations
Today’s Date: ______________
A. How old are you? ______
B. How far do you think you are in this pregnancy?
1
First trimester (less than 12 weeks)
2
Second trimester (more than 12 weeks)
3
I do not know
C. What were you doing to avoid pregnancy IN THE MONTH you got
pregnant this time? Check as many birth control methods as you were
using:


1. Condoms
2. The Pill
3. The 3 Month Shot, DepoProvera
4. The Patch, OrthoEvra
5. The Rhythm Method
6. Withdrawal, Pulling Out
7. Just Breast Feeding
8. The Vaginal Ring, NuvaRing
9. The IUD, Intrauterine Device, Mirena or ParaGard
10. Rod Implanted in Arm, Implanon or Nexplanon
11. Spermicide
12. Diaphragm
13. Morning After Pill, Emergency Contraception, Plan B,
Next Choice, Ella
14. Vasectomy of your partner
15. Tubal ligation, Your tubes tied
16. Nothing, I thought I wouldn’t get pregnant
17. Nothing, I wanted to be pregnant
18. Nothing, I did not have a choice
19. Other:____________________________________

Version 2 as of July 11, 2012
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D. If you were NOT using any method of pregnancy prevention when
you got pregnant, when was the last time you did use something to
prevent pregnancy?
1
2
3

Less than 3 months ago
Between 3 months and 6 months ago
More than 6 months ago

E. What have you EVER used for pregnancy prevention in your whole life?
CHECK ALL birth control methods that apply:


1. Condoms
2. The Pill
3. The 3 Month Shot, DepoProvera
4. The Patch, OrthoEvra
5. The Rhythm Method
6. Withdrawal, Pulling Out
7. Just Breast Feeding
8. The Vaginal Ring, NuvaRing
9. The IUD, Intrauterine Device, Mirena or ParaGard
10. Rod Implanted in Arm, Implanon or Nexplanon
11. Spermicide
12. Diaphragm
13. Morning After Pill, Emergency Contraception, Plan B,
Next Choice, Ella
14. Vasectomy of your partner
15. Tubal ligation, Your tubes tied
16. Nothing, I thought I wouldn’t get pregnant
17. Nothing, I wanted to be pregnant
18. Nothing, I did not have a choice
19. Other:____________________________________
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F. In the past two years, did you have an office visit with a health care
provider to talk about preventing pregnancy or about using birth control?
1

Yes

2

No

Please continue to the next question

Thank you! You may stop the survey and return
it to the PURPLE container marked “Pregnancy
Conversations SURVEYS” at the front desk.

G. What kind of office was this provider in?
1
Planned Parenthood
2
Obstetric/Gynecology (OB/GYN) Office
3
Private Medical Office
5
Community Health Center
6
Pediatric Office
7
Other: ___________________________

H. What kind of provider did you see for this birth control care?
1 Obstetrical/Gynecological (OB/GYN) Provider
2 General Medical Provider
3 Pediatric Provider
4 Not sure
5 Other:___________________________
I. How long have you been getting care with this provider?
1
Less than 6 months
2
6 to 12 months
3
1 to 2 years
4
More than 2 years
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J. Does this provider know that you are Pregnant?
1
Yes
2
No
SKIP to Question M below

K. If NO, do you think you will tell them about the Pregnancy?
1
Yes
2
No
3
Not sure
L. If you think you will NOT tell them about your Pregnancy,
Please CHECK ALL of the reasons you don’t want to tell them:
1
2
3
4
5
6
7
8

I’m embarrassed I got pregnant
I don’t want them to know I’m having an abortion
I’m afraid they will be disappointed in me
I’m afraid they will judge me
I’m afraid other people in my life may find out about the
pregnancy from their office
They do not provide abortions
I’m afraid my parents will find out
Other

reason:____________________________________
M. Does this provider know that you are having the Abortion?
1
Yes, and they referred me to an abortion provider
2
Yes, but they did NOT refer me to an abortion provider
3
N

SKIP to
Question P
on the next
page

N. If NO, do you think you will tell them about your Abortion?
1
Yes
2
No
3
No, but I will tell them I had a miscarriage
4
Not sure
O. If you think you will NOT tell them about your Abortion, Please
CHECK ALL of the reasons you don’t want to tell them:
1
2
3
4
5
6
7
8

I’m embarrassed I got pregnant
I don’t want them to know I’m having an abortion
I’m afraid they will be disappointed in me
I’m afraid they will judge me
I’m afraid other people in my life may find out about the
abortion from their office
They do not provide abortions
I’m afraid my parents will find out
Other reason:_________________________________

Version 2 as of July 11, 2012

49
P. How would you describe your ethnic background?
1
Hispanic or Latina
2
Not Hispanic or Latina
Q. How would you describe you racial background?
1
African-American or Black
2
Caucasian or White
3
Asian or Pacific Islander
4
Native American
5
Other: _________________________
R. What is the highest grade you have finished?
1
7th grade
2
8th grade
3
9th grade
4
10th grade
5
11th grade
6
12th grade
7
I got my GED
8
I am in college now
9
I have an associate’s degree
10 I have a bachelor’s degree
11 I have a graduate degree

S. What type of health insurance are you using to cover your abortion
today?
1
Private Insurance: _________________________
2
Medicaid
3
None, I’m paying for it myself.

T. What is your take-home household income in a year?
1
Less than $10,000
2
Between $10,000 and $20,000
3
Between $20,000 and $30,000
4
Between $30,000 and $40,000
5
More than $40,000 per year
6
Not sure
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U. What number pregnancy is this for you, including all births,
miscarriages, and abortions?
1
1st
2
2nd
3
3rd
4
4th
5
5th
6
6th or more
V. How many live births have you had?
1
None
2
1
3
2
4
3
5
4
6
5 or more
W. How many abortions (surgical or medication/pill) have you had before
today?
1
None
2
One
3
Two
4
Three or more
X. Are you planning on having a surgical or medication (pill) abortion
today?
1
Surgical Abortion
2
Medication (pill) Abortion
3
I don’t know

Thank you!
Please return this survey to the
PURPLE container marked
“Pregnancy Conversations
SURVEYS” at the front desk.
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